Nivolumab-Induced Hemophilia A Presenting as Gastric Ulcer Bleeding in a Patient With NSCLC-Reference-Cited by-同舟云学术

Nivolumab-Induced Hemophilia A Presenting as Gastric Ulcer Bleeding in a Patient With NSCLC

Published:2018-12 Issue:12 Volume:13 Page:e239-e241
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Kato Ryoji,Hayashi Hidetoshi,Sano Keigo,Handa Kohei,Kumode Takahiro,Ueda Hiroto,Okuno Tatsuya,Kawakami Hisato,Matsumura Itaru,Kudo Masatoshi,Nakagawa Kazuhiko

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference9 articles.

1. Acquired hemophilia A: updated review of evidence and treatment guidance;Kruse-Jarres;Am J Hematol,2017

2. Acquired factor VIII inhibitor in a patient with adenocarcinoma of the lung;Kondo;Jpn J Clin Oncol,1992

3. Acquired hemophilia and anti-Hu paraneoplastic neurologic syndrome in small cell lung cancer;Aggelopoulou;Am J Med Sci,2017

4. Hemophilia A induced by ipilimumab;Delyon;N Engl J Med,2011

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First reported use of immune checkpoint inhibitor for treatment of cancer in a patient with acquired hemophilia A;Clinical Immunology Communications;2024-06

2. Case Report: Effective management of adalimumab-induced acquired hemophilia A with the CyDRI protocol;Pathology and Oncology Research;2024-05-23

3. Exploring the intersection: Peptic ulcers and hemolysis—Unraveling the complex relationship;Medicine;2024-03-15

4. Rare Immune-Related Adverse Events (irAEs): Approach to Diagnosis and Management;Pharmaceutical Medicine;2024-01

5. Acquired bleeding disorders secondary to immune checkpoint inhibitors: a case report and systematic literature review;Blood Coagulation & Fibrinolysis;2023-09-08